CyberSecurity News
Biomemory Launches DNA Shield, First Commercial Product Built on Its Molecular IT Platform
Dark Reading
· October 16, 2026AI summary
Biomemory has introduced DNA Shield, its first commercial product based on its molecular IT platform. This launch comes after the company acquired certain assets and appointed Laurent Guengant as its CEO earlier in the year.
This is an AI-generated brief aggregated by HackerFeeds for convenience and grounded in the source’s own summary; the related CVE, threat-group and country data is from HackerFeeds’ own indexes. The original article is the authoritative source — all rights belong to Dark Reading.